Archive: May, 2014

 

 

AmpliPhi Announces Appointment of New Board Member – Wendy Johnson

AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014.

Read more about AmpliPhi Announces Appointment of New Board Member – Wendy Johnson

Avita Medical appoints new Chairman

Australia, 20 May 2014. Link here.

Read more about Avita Medical appoints new Chairman

ReCell® Spray-on Skin® demonstrates superior results treating hypopigmentation in aesthetic plastic surgery trial

Regenerative medicine company Avita Medical Limited “Avita Medical” (ASX:AVH) is pleased to announce that its product, ReCell, has been proven in a clinical study in Germany to provide clinically superior results for the treatment of hypopigmented scars.

Read more about ReCell® Spray-on Skin® demonstrates superior results treating hypopigmentation in aesthetic plastic surgery trial

Union MedTech plc raises £10 million to commercialise and develop REX, a hands-free robotic exoskeleton

Union MedTech plc today announces it is to be admitted to the AIM market of the London Stock Exchange with a market capitalisation of £25.7 million. On Admission, the acquisition by Union MedTech of REX Bionics Limited (“REX Bionics”) will complete and the Company will change its name to Rex Bionics plc.

Read more about Union MedTech plc raises £10 million to commercialise and develop REX, a hands-free robotic exoskeleton